Yüklüyor......

A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma

Bendamustine is approved in the United States for relapsed indolent lymphoma. However, it has not been widely studied in mantle cell lymphoma (MCL). We retrospectively reviewed the records of all patients with MCL who were treated with bendamustine at three centers. The primary endpoint was overall...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Leuk Lymphoma
Asıl Yazarlar: Warsch, Sean, Hosein, Peter J., Maeda, Lauren S., Alizadeh, Ash A., Lossos, Izidore S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570573/
https://ncbi.nlm.nih.gov/pubmed/22185662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.649476
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!